Cefixima Aurobindo

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefixima Aurobindo

Property Description
Active ingredient Cefixime
Form Oral tablet or suspension
Pharmacological class Third-Generation Cephalosporin Antibiotic
Common use Treating bacterial infections
Origin Synthetic compound

Cefixime Aurobindo is a generic prescription medication containing the single active ingredient, cefixime. This synthetic compound is manufactured by Aurobindo Pharma and is administered via the oral route, typically supplied as film-coated tablets or a liquid oral suspension. As a generic product, it is clinically recognized for being bioequivalent to the original innovator drug, providing the same high-quality active ingredient in the same strength.

What Type of Antibiotic is Cefixime?

Cefixime is officially classified as a third-generation cephalosporin antibiotic, a designation widely used in medical practice. This class is valued because it offers a broad-spectrum bactericidal effect, meaning it is formulated to actively kill a wide array of bacterial strains. Cefixime is a reliable and effective agent for treating uncomplicated infections caused by susceptible organisms. The drug's primary function is based on eliminating the bacterial pathogens responsible for illness.

What is Cefixime Aurobindo Prescribed For? (Therapeutic Purpose)

The general therapeutic purpose of Cefixime Aurobindo is the management of various acute bacterial infections. It is a standard treatment for situations where susceptible organisms are the cause, including infections of the respiratory system, middle ear, and urinary tract. It is critical to remember that this antibiotic is reserved exclusively for bacterial illnesses and is wholly ineffective against infections caused by viruses, such as the common cold or influenza.

Regulatory References

  1. MedlinePlus Drug Information on Cefixime
  2. NIH PubMed ID: 38706366 (Abstract)

What side effects are possible with Cefixima Aurobindo?

Possible Side Effects and Safety Information

Cefixime, the active ingredient in Cefixima Aurobindo, has a safety profile established through clinical data and regulatory review. Adverse reactions are formally classified by frequency and affected physiological system according to official standards set by government health authorities.

Frequency-Classified Adverse Reactions

The most frequently documented side effects are categorized as Common (1 to 10 users in 100) and primarily involve the Gastrointestinal System, including diarrhea, abdominal pain, and loose stools. Uncommon effects (1 to 10 users in 1,000) may include headache, dizziness, nausea, vomiting, and skin rash. Rare and Very Rare classifications cover events like drug fever, severe skin reactions (e.g., Stevens-Johnson Syndrome), and serious blood disorders (e.g., thrombocytopenia).

Serious and Clinically Significant Reactions

Official prescribing information highlights specific, potentially severe adverse reactions. These include anaphylactic reactions (severe allergic responses) and pseudomembranous colitis, a form of severe diarrhea caused by Clostridium difficile that can occur during or after therapy. The regulatory text also addresses the risk of acute renal failure and hepatitis as very rare, but serious, documented effects.

Safety Considerations

High-level safety constraints note that cefixime is contraindicated in patients with a history of allergy to cephalosporins or any severe reaction to other beta-lactam antibiotics like penicillins. Additionally, special caution and monitoring are advised for individuals with markedly impaired renal function, as this may affect the drug's safety profile. The potential for the antibiotic to cause interference with certain laboratory tests, such as the Coombs test, is also noted in regulatory labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define Cefixime overdose by the potential for severe, documented clinical manifestations and specific emergency actions required.

A suspected overdose may present with an increase in the severity of known adverse reactions, most commonly including pronounced gastrointestinal disturbances such as nausea, vomiting, and diarrhea.

Severe Outcomes and Required Actions

The most critical documented outcome involves the Central Nervous System (CNS). Exposure to high doses is associated with the risk of reversible encephalopathy, which may lead to convulsions and seizures. This risk is officially noted to be significantly elevated in patients with compromised renal function due to impaired drug clearance.

In any instance of suspected overdose, the regulatory labeling mandates that individuals seek immediate medical attention. Emergency services must be contacted if severe neurological signs, such as convulsions or loss of consciousness, occur.

Management and Antidote Status

The management of Cefixime overdose is symptomatic and supportive. Regulatory sources confirm that no specific antidote is known for Cefixime. Supportive measures, including general hospital monitoring and consideration of procedures like gastric lavage, are required. Official information states that elimination via hemodialysis or peritoneal dialysis is not considered an effective method for drug removal.

Therapeutic Uses of Cefixima Aurobindo

What Cefixima Aurobindo Treats: Main Uses and Benefits

The primary therapeutic role of Cefixime Aurobindo is the management of certain infections caused by susceptible bacteria across domains involving specific symptom patterns.

The medication is applied across therapeutic domains involving acute or disruptive symptom patterns, including those from acute otitis media, pharyngitis/tonsillitis, acute exacerbations of bronchitis, and uncomplicated urinary tract infections (UTIs). The use is generally reserved for conditions associated with symptoms that are confirmed or suspected to be bacterial in origin.

In these situations, Cefixime Aurobindo supports the easing of symptoms related to inflammatory or irritative states, such as severe throat pain, ear pressure, and painful urination. This application contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

Quick Fact: Managing Symptoms Associated with Acute Discomfort

The drug is commonly used for acute episodes where symptoms interfere with daily functioning, providing supportive relief that helps patients cope more steadily with symptom fluctuations.

Regulatory References

  1. National Institutes of Health’s DailyMed service

Eligibility and Restrictions for Use

Official Eligibility Rules for Cefixima Aurobindo

Cefixima Aurobindo (cefixime) is a third-generation cephalosporin antibiotic with specific regulatory rules defining patient eligibility. These rules are established by official government labeling to ensure appropriate use.

Populations Excluded (Contraindicated)

Cefixima Aurobindo is contraindicated and must not be used in patients with a known allergy or severe hypersensitivity to:

  • Cefixime, the active ingredient, or any other components of the medicine.
  • Any other drug belonging to the cephalosporin class of antibiotics.
  • A history of severe, immediate hypersensitivity reactions to penicillins or any other beta-lactam antibiotics, due to the risk of cross-allergy.

Age-Related Eligibility Status

Age Group Eligibility Status Regulatory Finding
Infants (< 6 months) Not Established Safety and efficacy have not been established in this age group.
Pediatric (≥ 6 months) Approved The drug is indicated for patients six months of age and older.
Adults Approved Approved for use under standard labeled conditions.
Older Adults Approved May use the adult dose, but renal function should be assessed.

Conditional Use and Restrictions

Eligibility is restricted or requires caution for certain physiological conditions, primarily involving organ health:

  • Severe Renal Impairment: Use is conditional. Dose adjustment is officially required for adults whose creatinine clearance is less than 60 mL/min.
  • Gastrointestinal History: Patients with a history of gastrointestinal disease, such as colitis, should use the medicine with caution.
  • Pregnancy: The drug is classified as Pregnancy Category B and should be used during pregnancy only if clearly needed.
  • Lactation: It is unknown if the drug is excreted in human milk; consideration should be given to temporarily discontinuing nursing during treatment.

What should I know about interactions with other medicines?

This section summarizes the officially documented interaction profile of Cefixima Aurobindo (cefixime), as defined by government regulatory agencies, detailing specific restrictions and known outcomes.

Official Interaction Patterns

Interacting Substance/Class Official Regulatory Statement
Warfarin & Anticoagulants Co-administration is formally associated with a pharmacodynamic interaction causing an increase in prothrombin time (PT prolongation), with reported risk of bleeding events.
Carbamazepine This antibiotic may lead to elevated plasma concentrations of Carbamazepine, a reported pharmacokinetic outcome requiring monitoring during co-administration.
Live Bacterial Vaccines Regulatory consensus requires the restriction of Cefixime use with Live Bacterial Vaccines (e.g., Cholera, Typhoid) due to potential decreased vaccine efficacy.
Hormonal Contraceptives Official summaries state that use may decrease the effectiveness of estrogen- and progestin-containing oral contraceptive products.

Constraints and Population-Specific Notes

Constraint Type Regulatory Statement
Food & Timing Ingestion of food slows the rate of Cefixime absorption (Tmax is increased) but does not significantly alter the total absorbed amount (AUC). No mandatory timing separation is required for administration.
Excipient Restriction Formulations provided as chewable tablets contain phenylalanine, resulting in a formal restriction for use in individuals with Phenylketonuria (PKU).
Renal Function Patients with renal impairment experience slower Cefixime elimination, increasing the potential for drug accumulation and heightened risk of coagulation effects.

Mechanism of Action

Covalent Inhibition of Bacterial Cell Wall Construction

Cefixime acts directly as a highly specific inhibitor of bacterial Penicillin-Binding Proteins (PBPs), which are essential enzymes responsible for the final cross-linking step in the peptidoglycan synthesis pathway. This irreversible molecular action permanently blocks the construction of the bacteria's rigid external structure.

Mechanism of Bactericidal Cell Lysis

The structural failure resulting from PBP inhibition leads to a critical loss of integrity in the bacterial cell wall. Unable to withstand its internal osmotic pressure, the cell rapidly ruptures, a fatal process known as lysis. This mechanism leads to the bactericidal effect, which is the destruction of the bacterial cell.

Selectivity and Mechanistic Resistance

The drug's mechanism is highly selective, targeting enzymes and structures unique to bacteria, resulting in high specificity for bacterial structures and enzymes. Furthermore, the molecule is designed with enhanced stability, allowing it to resist inactivation by many common bacterial beta-lactamase enzymes, which allows the mechanism to proceed by preventing enzymatic degradation.

Dosage and Administration Information

How to Use Cefixima Aurobindo

Cefixima Aurobindo is administered exclusively via the oral route, with official instructions governing the standard dosage, frequency, and preparation requirements based on the drug's regulatory labeling.


Official Dosing and Regimens

The standard adult dose of cefixime is 400 mg daily. This may be taken as a single 400 mg dose or as 200 mg every 12 hours. For specific infections, such as uncomplicated Gonorrhea, a single oral dose of 400 mg is the recommended regimen. The full course of treatment typically lasts 7 to 14 days, but must be administered for at least 10 days when treating infections caused by Streptococcus pyogenes.

Population Group Labeled Dosing Instruction
Standard Adults 400 mg once daily or 200 mg twice daily.
Pediatric Patients (6 mos+) 8 mg/kg/day of the oral suspension, administered once daily or divided every 12 hours.
Renal Impairment If creatinine clearance is less than 20 mL/min, the dose should not exceed 200 mg once daily.

Administration Requirements

  • Food: Capsules and tablets may be administered without regard to food.
  • Suspension Preparation: The oral suspension must be reconstituted with water and shaken well before each dose. Patients must ensure the correct concentration is used when dosing by volume.
  • Missed Dose: If a dose is missed, it should be taken as soon as the patient remembers. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Double doses should not be taken to compensate for a missed dose.

Recent Clinical Evidence

Evidence for Use in Common Acute Infections

Research has explored Cefixima Aurobindo in studies focusing on acute respiratory conditions (such as pharyngitis and acute bronchitis), acute otitis media (middle ear infections), and uncomplicated urinary tract infections (UTIs). These investigations typically involve short-term randomized controlled trials (RCTs) and comparative studies. Researchers focused on tracking the clinical resolution of signs and symptoms and monitoring outcomes related to pathogen eradication in both adult and pediatric populations.

Findings described patterns observed that were consistent with patterns established in the broader evidence landscape for these infections. Reports indicated that outcomes monitoring physiological strain or stress showed certain measurements against specific common pathogens, such as penicillin-resistant S. pneumoniae, suggesting challenges in achieving expected eradication outcomes against these strains.

Evidence in Specialized Contexts and Gaps

The drug's use was studied for certain highly specific conditions, such as uncomplicated gonorrhea. This research utilizes systematic reviews and ongoing surveillance data to monitor bacterial susceptibility. Studies have reported changes associated with emerging resistance, which highlights that certainty remains low due to the rapid evolution of resistance patterns in the target pathogen.

Research examined the drug's use in special groups, including pediatric subjects aged 6 months and older, but few data are available for infants younger than 6 months. Overall, clinical trials for most acute infections involve short-term observation periods, meaning long-term effects are not fully established and comparative evidence is lacking against all available standard treatments in the current research landscape.

Frequently Asked Questions (FAQ)

Common questions about Cefixima Aurobindo (FAQ)


Q: How quickly should Cefixima Aurobindo start working after taking it?

A: Studies on the drug's activity indicate that the highest concentration of the medicine in the blood is typically reached between 2 and 6 hours after an oral dose. This peak shows the medicine is active in the system, but the resolution of symptoms depends on the infection type. It is important to complete the full treatment course as prescribed.


Q: Why is Cefixima Aurobindo sometimes prescribed instead of Amoxicillin?

A: Cefixima Aurobindo is a third-generation cephalosporin antibiotic, which has a different mode of action than penicillins like Amoxicillin. Regulatory information states this class of antibiotic is formulated to be stable against many beta-lactamase enzymes produced by bacteria. This allows Cefixima Aurobindo to be active against bacterial strains that may be resistant to some older drugs.


Q: Are there any specific foods to avoid when taking Cefixima Aurobindo?

A: Official administration instructions state that the tablets and capsules can be taken without regard to food. While taking it with food may slightly slow the rate at which the medicine is absorbed, it does not significantly change the total amount of medicine absorbed. There are no mandatory specific foods that must be avoided.


Q: Is Cefixima Aurobindo safe to use during pregnancy?

A: The drug is classified as Pregnancy Category B according to official regulatory documents, meaning studies have not shown harm in animal models. Its use during pregnancy is recommended only if the treating healthcare provider determines it is clearly needed for the patient's condition.


Q: Is it normal to feel tired after starting Cefixima Aurobindo?

A: Tiredness or fatigue is not consistently listed as one of the common or uncommon side effects in the official product information. However, other neurological effects, such as headache and dizziness, have been reported by some users. Any unusual or concerning fatigue should be reported to a healthcare professional.


Q: Does Cefixima Aurobindo affect birth control pills?

A: Yes, official drug interaction warnings indicate that using this antibiotic may decrease the effectiveness of hormonal contraceptive products that contain estrogen and progestin. Patients using hormonal contraceptives should consult a healthcare professional regarding alternative contraception options during treatment.


Q: Can Cefixima Aurobindo cause diarrhea, and what helps with it?

A: Diarrhea and loose stools are the most frequently documented side effects for this medication. For managing diarrhea, patients should consult a healthcare professional, as taking certain over-the-counter antidiarrheal medicines may inadvertently worsen or prolong the condition, especially if the diarrhea is severe.


Q: How long does Cefixima Aurobindo stay in your system?

A: The time it takes for the concentration of the medicine to drop by half in the bloodstream (the half-life) is typically about 3 to 4 hours. This elimination process may be prolonged for patients who have impaired kidney function, as this condition can slow the removal of the drug from the body.


Q: Can Cefixima Aurobindo affect my liver function?

A: Official prescribing information notes that transient elevations in liver enzymes have been reported in some patients. More serious conditions, such as hepatitis (liver inflammation) and jaundice, have been reported as very rare adverse reactions. If there are pre-existing liver conditions, a healthcare professional should be aware before treatment begins.


Q: Are there any long-term effects of taking Cefixima Aurobindo?

A: The clinical trials conducted for most acute infections involve short-term observation periods. Because of this, the official research evidence states that long-term effects are not fully established, and comparative evidence against all available standard treatments is still developing.


Q: What is the difference between Cefixima Aurobindo and other Cefixime brands?

A: Cefixima Aurobindo is a generic prescription medication containing the active ingredient cefixime. It is officially recognized as bioequivalent to the original branded drug, meaning it contains the same active ingredient at the same strength and works the same way in the body. The 'Aurobindo' part of the name identifies the manufacturer.


Q: Can Cefixima Aurobindo be crushed or split?

A: The official product information provides instructions for preparing the oral suspension (liquid) form. However, regulatory documents do not provide explicit instructions for crushing or splitting the solid tablets or capsules. If there is a need to alter the tablet or capsule form, consult a pharmacist or prescribing physician.


Q: Is Cefixima Aurobindo safe for people with penicillin allergies?

A: Cefixima Aurobindo is contraindicated (must not be used) in patients with a history of allergy to cephalosporins. There is also a risk of cross-allergy, so it is contraindicated in patients with a history of severe, immediate hypersensitivity reactions to penicillins or other beta-lactam antibiotics.


Q: What precautions should be taken when giving Cefixima Aurobindo to someone with kidney problems?

A: Patients with impaired kidney function must use the medicine with caution because drug elimination is slower. The adult dose must be adjusted or reduced if the patient has severe renal impairment. Monitoring of blood clotting time (prothrombin time) is also officially advised in these patients.


Q: Is Cefixima Aurobindo safe for people who are breastfeeding?

A: Official regulatory information states that it is currently unknown whether the drug is excreted in human milk. Because of this lack of certainty, consideration should be given to temporarily discontinuing nursing for the duration of the treatment course.


Q: What should I do if a side effect from Cefixima Aurobindo seems serious?

A: Official safety constraints highlight the risk of serious reactions, such as anaphylaxis or pseudomembranous colitis. A healthcare professional should be contacted immediately if a patient develops signs of a severe allergic reaction or severe, watery diarrhea, as these require prompt medical evaluation.


Q: Can Cefixima Aurobindo cause a yeast infection?

A: While the primary side effects are typically gastrointestinal, the official information on antibiotics notes that prolonged use may lead to an overgrowth of non-susceptible organisms. This includes fungi, which can sometimes result in secondary infections like oral or vaginal candidiasis (yeast infection).


Q: Is the 'Aurobindo' part of the name important to know?

A: 'Aurobindo' is the name of the pharmaceutical company that manufactures this specific generic version of the active ingredient, cefixime. While all generic versions are required to meet the same quality and bioequivalence standards, the name identifies the product's source.


Q: Does Cefixima Aurobindo interact with antacids or acid-blockers?

A: Official regulatory warnings do not consistently list antacids or acid-blockers as mandatory interactions. However, some documents note that taking the medicine with other compounds, such as high-dose salicylates, may decrease the peak serum concentration of the antibiotic.


Q: Can Cefixima Aurobindo affect your sleep?

A: Sleep disturbance, such as insomnia, is not a commonly listed side effect in the official product labeling. However, it is a medication that acts on the whole body, and some patients may experience neurological effects such as dizziness or headaches.


Q: Is there a risk of antibiotic resistance with Cefixima Aurobindo?

A: Yes, regulatory warnings state that prescribing the antibiotic in the absence of a proven or strongly suspected bacterial infection increases the risk of the development of drug-resistant bacteria. For this reason, official warnings emphasize that the medicine should be used only for confirmed bacterial illnesses.


Q: What should I expect in terms of duration of treatment with Cefixima Aurobindo?

A: The full course of treatment typically lasts 7 to 14 days. Official guidance notes that the specific duration prescribed will depend entirely on the type, location, and severity of the bacterial infection being treated.

How should Cefixima Aurobindo be stored and disposed of?

How to Store and Dispose of Cefixime Aurobindo?

The official storage conditions for Cefixime vary between the solid and liquid forms.


Storage Requirements

  • Tablets/Capsules: Must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The solid form must be protected from freezing, moisture, and direct light.
  • Oral Suspension: The unreconstituted powder must not exceed 30 C. The reconstituted liquid is stable for 14 days when stored at room temperature or refrigerated, but it must not freeze.

Disposal and Safety

All forms of the medicine must be kept out of the reach of children. The reconstituted liquid must be discarded after 14 days. Outdated or unused portions of the medicine should be disposed of by following the guidance of a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefixima Aurobindo found in:

A-Z Index: